Canadian application, no grantCanada
Ex vivo treatment of allogeneic and xenogeneic t-cells with gp39 antagonists
CA 2338773 A1 · Owner: Regents Of The University Of Minnesota · Inventors: Taylor, Patricia A.; Vallera, Daniel A.; Noelle, Randolph J.
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods for inducing T-cell non-responsiveness to donor T-cells comprised in transplantation tissues are provided. The methods involve ex vivo treatment of donor T-cells with gp39 antagonists.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 29, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 29, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 29, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 29, 1999
GrantedNo grant recorded
Term endedJuly 29, 2019
Patent numberCA 2338773 A1
Classification (IPC)C12N5/07 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.